Absolute Bioavailability of Intranasal HCl in Patients with Rhinitis and Rhinitis Treated with Oxymetazoline (HM9905)

Grants and Contracts Details

StatusFinished
Effective start/end date7/1/002/28/02

Funding

  • Inhalation Technology Inc: $75,552.00